Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual
DGAP-News: Sernova Corp. / Key word(s): Study results/Study05.01.2022 / 15:25 The issuer is solely responsible for the content of this announcement.LONDON, ONTARIO - January 5, 2022 - Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage regenerative medicine and cell therapy therapeutics company...